BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Al Delbany D, Robert V, Dubois-Vedrenne I, Del Prete A, Vernimmen M, Radi A, Lefort A, Libert F, Wittamer V, Sozzani S, Parmentier M. Expression of CCRL2 Inhibits Tumor Growth by Concentrating Chemerin and Inhibiting Neoangiogenesis. Cancers (Basel) 2021;13:5000. [PMID: 34638484 DOI: 10.3390/cancers13195000] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Torphy RJ, Yee EJ, Schulick RD, Zhu Y. Atypical chemokine receptors: emerging therapeutic targets in cancer. Trends in Pharmacological Sciences 2022. [DOI: 10.1016/j.tips.2022.09.009] [Reference Citation Analysis]
2 Lavis P, Morra S, Orte Cano C, Albayrak N, Corbière V, Olislagers V, Dauby N, Del Marmol V, Marchant A, Decaestecker C, Mascart F, De Vos N, Van de Borne P, Salmon I, Remmelink M, Parmentier M, Cardozo AK, Bondue B. Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality. Front Immunol 2022;13:941663. [DOI: 10.3389/fimmu.2022.941663] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wang Q, Wang H, Ding Y, Wan M, Xu M. The Role of Adipokines in Pancreatic Cancer. Front Oncol 2022;12:926230. [DOI: 10.3389/fonc.2022.926230] [Reference Citation Analysis]
4 Ben Dhaou C, Del Prete A, Sozzani S, Parmentier M. CCRL2 Modulates Physiological and Pathological Angiogenesis During Retinal Development. Front Cell Dev Biol 2021;9:808455. [PMID: 35004698 DOI: 10.3389/fcell.2021.808455] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]